Although Costco (COST) has shown no noticeable covid impact the last two quarters, the company’s outlook for the next six months will indicate whether it believes it has what it takes to keep gaining market share from its brick-and-mortar competitors.
Brian Overby, Senior Options Analyst at Ally Invest and author of The Options Playbook, recently joined the Option Block Podcast on the Options Insider Radio Network to talk volatility and the options market.
We highlight some of the Investor Relations Officers who perform beyond the traditional role of the IRO, covering a wide array of global companies in various sectors with a combined market cap of about $230 billion.
Plant-based alternatives have enjoyed an explosion in demand as consumers embrace healthier lifestyles amid growing concerns over environmental repercussions from animal-based proteins.
The Trade Ideas Trade of the Week for each week in November. A summary showing the number of times that HOLLY traded in the industry and what was the profit or loss associated with those trades.
Advanced technologies such as artificial intelligence, machine learning, and natural language processing have been deployed in the battle against Covid-19 since the pandemic’s earliest days.
Today the U.S. House of Representatives votes on a one-week stopgap funding bill that will provide more time for lawmakers to reach a deal on both COVID-19 relief and an overarching spending bill to avoid a government shutdown
When the coronavirus upended the U.S. economy in March, capital markets convulsed. And yet, everything turned out alright for equities – in fact, better than alright.
Apple (AAPL) is not a news-sensitive stock. When a company gets to that big a market cap and has such a large, diverse product range, a single news story rarely produces a big reaction in the stock price.
The rule couldn’t come at a better time. We are living through a yield crisis where treasuries are under 1% and historical volatility in the stock market amidst a pandemic.
Despite the progress on the vaccine front, markets are once again focusing on the continued climb in COVID-19 cases and the ensuing impact on the global economy and earnings as equities once again flirt (shamelessly) with record highs